Invention Grant
- Patent Title: Benzodiazepine bromodomain inhibitor
- Patent Title (中): 苯二氮卓溴结构域抑制剂
-
Application No.: US13504971Application Date: 2010-11-03
-
Publication No.: US09102677B2Publication Date: 2015-08-11
- Inventor: James Bailey , Romain Luc Marie Gosmini , Olivier Mirguet , Jason Witherington
- Applicant: James Bailey , Romain Luc Marie Gosmini , Olivier Mirguet , Jason Witherington
- Applicant Address: US DE Wilmington
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US DE Wilmington
- Agent Robert H. Brink
- Priority: GB0919433.3 20091105; GB1010509.6 20100622; WOPCT/EP2010/061518 20100806; GB1014231.3 20100825
- International Application: PCT/EP2010/066697 WO 20101103
- International Announcement: WO2011/054845 WO 20110512
- Main IPC: A61K31/55
- IPC: A61K31/55 ; C07D487/04
Abstract:
Benzodiazepine compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and their use in therapy.
Public/Granted literature
- US20120252781A1 Benzodiazepine Bromodomain Inhibitor Public/Granted day:2012-10-04
Information query
